Portfolio Lab

Oscar Health, Inc.

  • Stock
  • Ticker OSCR
  • ISIN US6877931096
  • NYSE

Health care · Health care services · USA

$24.73 −5.50%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Oscar Health, Inc. since 03/2021, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

OSCRGlobal equities (VT)

$10,000 grew to $14,311. Global equities (VT): $14,653.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −94.2% in 12/2022, measured from the peak in 03/2021. The old peak has not been reached again yet.

1-year return
+89.8%
5-year return p.a.
+19.1%
Return p.a. since 03/2021
−5.8%
Volatility p.a.
81.4%
Largest decline
−94.2%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue2,3923,0462,8642,9862,8054,6474,8805,139
Operating income-148297-230-129-334704389178
EBITDA-138304-224-122-326711395185
Net income-154275-228-137-353679362167
Earnings per share-0.550.92-0.89-0.53-1.342.071.100.49
Balance sheet
Total assets4,8405,8446,3845,7466,3259,29011,22710,009
Liabilities3,8244,5085,2234,7195,3457,6239,1727,783
Equity1,0141,3331,1581,0249781,6642,0522,223
Cash1,5272,2372,5992,1492,7744,8054,0764,467
Long-term debt300300300686430431432432
Cash flow
Operating cash flow347879509-9656722,6192,092-1,201
Capital expenditure-6.8-9.0-9.3-9.0-9.1-8.8-12-11
Free cash flow340870500-9746632,6102,081-1,212

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2023 at +272.0%, weakest 2022 at −68.7%. 3 of 4 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
5 Nov 2026$0.49
7 Aug 2026$1.10
7 May 2026$2.07
13 Feb 2026−$1.34
6 Nov 2025−$0.53
7 Aug 2025−$0.89
8 May 2025$0.92
20 Feb 2025−$0.55
7 Nov 2024−$0.22
7 Aug 2024$0.20
7 May 2024$0.62
15 Feb 2024−$0.67

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€7.8bn
Market cap in trading currency
$8.57bn
Enterprise value
$1.51bn
P/E
10.7
P/S
0.49
P/B
3.85
EV/Sales
0.09
EV/EBITDA
1.6
Earnings yield
9.4%
FCF yield
48.3%

Results (last four quarters)

Revenue
$17.5bn
Gross profit
–
EBITDA
$964m
Net income
$855m
Earnings per share
$2.32
Revenue per share
$50.43
Revenue growth
+72.1%
Earnings growth
–

Profitability

Gross margin
–
Operating margin
5.4%
Net margin
4.9%
Return on equity
52.7%
Return on assets
8.5%

Balance sheet and cash flow

Cash
$7.49bn
Cash per share
$21.61
Financial debt
$432m
Debt/equity %
19
Current ratio
1.14
Book value per share
$6.42
Operating cash flow
$4.18bn
Free cash flow
$4.14bn

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
346m
Volume
6.52m
Avg. volume 3 months
5.24m
Relative volume
1.2

Price and technicals

Price
$24.73
1 day
−5.5%
52-week high
$35.19
52-week low
$10.85
Distance to 52-week high
−29.7%
Distance to 52-week low
+127.9%
Distance to 50-day line
−21.6%
Distance to 200-day line
−0.2%
RSI (14)
30
Volatility 1M
72.9%

Performance

1 week
−20.4%
1 month
−25.8%
3 months
−22.3%
6 months
+9.2%
YTD
+72.1%
1 year
+75.6%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has OSCR performed since 03/2021?

$10,000 grew to $7,106 by 20 Nov 2026, which is −5.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is OSCR?

Volatility was 81.4% per year, measured on monthly returns. The largest decline from a peak was −94.2%, with the low in 12/2022.

How does OSCR compare with a broad equity ETF?

Over the same period Global equities (VT) returned +9.3% per year at 14.8% volatility, OSCR returned −5.8% at 81.4%. The correlation of monthly returns was 0.44; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Oscar Health, Inc. (OSCR): Return and risk | Portfolio Lab